References
- Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313–321.e2.
- Harbord M, Eliakim R, Bettenworth D, European Crohn’s and Colitis Organisation [ECCO], et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis. 2017;11(7):769–784.
- Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn’s disease: medical treatment. J Crohns Colitis. 2020;14(1):4–22.
- Alulis S, Vadstrup K, Borsi A, et al. Treatment patterns for biologics in ulcerative colitis and Crohn’s disease: a Danish nationwide register study from 2003 to 2015. Scand J Gastroenterol. 2020;55(3):265–271.
- Wong DJ, Roth EM, Feuerstein JD, et al. Surgery in the age of biologics. Gastroenterol Rep (Oxf). 2019;7(2):77–90.
- Perera S, Yang S, Stott-Miller M, et al. Analysis of healthcare resource utilization and costs after the initiation of biologic treatment in patients with ulcerative colitis and Crohn’s disease. J Health Econ Outcomes Res. 2018;6(1):96–112.
- Larsen L, Drewes AM, Broberg MCH, et al. Changing infliximab prescription patterns in inflammatory bowel disease: a population-based cohort study, 1999–2014. Inflamm Bowel Dis. 2018;24(2):433–439.
- Nguyen GC, Laveist TA, Gearhart S, et al. Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol. 2006;4(12):1507–1513.
- Rencz F, Péntek M, Bortlik M, et al. Biological therapy in inflammatory bowel diseases: access in central and eastern Europe. World J Gastroenterol. 2015;21(6):1728–1737.
- Raine T, Gkini MA, Irving PM, et al. Maintaining clinical freedom whilst achieving value in biologics prescribing: an integrated cross-specialty consensus of UK dermatologists, rheumatologists and gastroenterologists. BioDrugs. 2021;35(2):187–199.
- STATACorp. Stata Statistical Software.
- Fonager K, Sørensen HT, Rasmussen SN, et al. Assessment of the diagnoses of Crohn’s disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol. 1996;31(2):154–159.
- Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
- Meijer M, Röhl J, Bloomfield K, et al. Do neighborhoods affect individual mortality? A systematic review and meta-analysis of multilevel studies. Soc Sci Med. 2012;74(8):1204–1212.
- Diderichsen F. Ulighed i Sundhed 2012.
- Berg DR, Colombel J-F, Ungaro R. The role of early biologic therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(12):1896–1905.
- Danish National Guidelines. https://www.dsgh.dk/index.php/ibd/biologisk-terapi-behandling